Occlusion Devices Market Growth Projection: Expected to Surpass $6.54 Billion by 2030 at 9.2% CAGR
Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What growth pattern is forecast for the Occlusion Devices Market size between 2026 and 2035?
The market size for occlusion devices has experienced substantial growth in recent years. This market is projected to expand from $4.2 billion in 2025 to $4.6 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.6%. Historically, this expansion can be attributed to several factors including an increase in cardiovascular diseases, advancements in interventional radiology, the growth of the aging population, the expansion of hospital infrastructure, and the clinical adoption of embolization.
The occlusion devices market is projected for significant expansion over the coming years, anticipated to reach $6.54 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. Factors contributing to this growth throughout the forecast period include an increase in neurological disorders, a surge in minimally invasive surgical procedures, advancements in device technology, the proliferation of ambulatory care facilities, and supportive reimbursement frameworks. Key developments expected during this timeframe involve a move towards less invasive methods, an uptick in the application of catheter-based treatments, a growing inclination for embolization techniques, the expansion of neurovascular interventions, and a need for highly accurate occlusion devices.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20584&type=smp
Which Drivers Are Impacting Market Performance In The Occlusion Devices Market?
The expansion of the occlusion devices market is anticipated to be fueled by the increasing requirement for minimally invasive techniques. Minimally invasive surgeries involve surgical methods employing small cuts or natural bodily orifices to access and address internal structures, organs, or tissues, thereby reducing patient trauma. These techniques offer medical, financial, and aesthetic advantages that attract both patients and healthcare providers, consequently boosting their adoption across diverse medical fields. Within minimally invasive procedures, occlusion devices are medical instruments utilized to obstruct or seal blood vessels, ducts, or other bodily conduits. Frequently, these instruments find application in areas like interventional cardiology, radiology, or other specialties for managing conditions including aneurysms, atypical blood flow, or congenital heart issues. As an illustration, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS) disclosed that during 2023, the total count of aesthetic procedures neared 35 million, with both surgical and non-surgical procedures combined showing a 3.4% increase, amounting to 34.9 million. Consequently, the heightened demand for minimally invasive techniques is a key driver for the expansion of the occlusion devices market.
What Segment Types Are Examined In The Occlusion Devices Market?
The occlusion devices market covered in this report is segmented –
1) By Product: Occlusion Removal Devices, Embolization Devices, Tubal Occlusion Devices, Support Devices
2) By Application: Neurology, Cardiology, Peripheral Vascular Diseases, Urology, Oncology, Gynecology
3) By End User: Hospitals Diagnostic Centers And Surgical Centers, Ambulatory Care Centers, Research Laboratories And Academic Institutes
Subsegments:
1) By Occlusion Removal Devices: Thrombectomy Devices, Catheter-Based Occlusion Removal Devices, Aspiration Systems, Mechanical Clot Retrieval Systems
2) By Embolization Devices: Coil Embolization Devices, Particle Embolization Devices, Balloon Embolization Devices, Gel Embolic Agents, Liquid Embolic Agents, Stent-Assisted Embolization Devices
3) By Tubal Occlusion Devices: Essure Devices, Hysteroscopic Sterilization Systems, Fallopian Tube Clips, Tubal Ligation Devices
4) By Support Devices: Occlusion Catheters, Guidewires For Occlusion, Supportive Sheaths, Stent-Grafts For Occlusion Support
What Trends Are Expected To Impact The Competitive Landscape Of The Occlusion Devices Market?
Leading companies in the occlusion devices market are prioritizing the development of innovative solutions, including advanced next-generation devices, to improve targeted embolization procedures. A next-generation device represents an upgraded version of existing technology, providing enhanced performance, superior features, and novel capabilities. For instance, in July 2025, Embolx, a US-based medical equipment manufacturer, unveiled the Sniper G3 Balloon Occlusion Microcatheter, which markedly enhances targeted embolization by offering greater efficiency, ease of operation, and an extended shelf life. This third-generation device extends its shelf life to 24 months, thereby enabling improved inventory flexibility. Developed with direct insights from interventional radiologists, it features better trackability and a simplified preparation process that reduces setup time to under a minute. These advancements underscore Embolx’s dedication to physician-centered design, aiming to streamline clinical workflows and optimize procedural outcomes. The Sniper G3 is offered in all standard lengths and is prepared for global distribution, solidifying its reputation as a leading instrument in embolization therapy.
Who Are The Major Companies Operating In The Occlusion Devices Market?
Major companies operating in the occlusion devices market are Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Lepu Medical Technology Beijing Co. Ltd., MicroPort Scientific Corporation, Penumbra Inc., Asahi Intecc Co. Ltd., Angiodynamics Inc., LeMaitre Vascular Inc., Elixir Medical Corporation, Vascular Concepts Ltd., Occlutech, W L Gore & Associates Inc., LifeTech Scientific Corporation, Cardiovascular Systems Inc., Venus Medtech, CeloNova Biosciences, Cordis Corporation, Pfizer Inc., Sirtex Medical Limited, Nordion Canada Inc., AtriCure Inc., Phenox GmbH, Balt Extrusion SAS
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/occlusion-devices-global-market-report
Which Region Is Anticipated To See The Fastest Growth In The Occlusion Devices Market?
North America was the largest region in the occlusion devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the occlusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Occlusion Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20584&type=smp
Browse Through More Reports Similar to the Global Occlusion Devices Market 2026, By The Business Research Company
Chronic Venous Occlusions Treatment Global Market Report 2026
Cardiovascular Surgery Devices And Equipment Global Market Report 2026
Peripheral Vascular Devices And Equipment Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
